This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (337) Coronary Heart Disease (53)

Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19456, first published .
Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial

Authors of this article:

Rebecca Maier 1 Author Orcid Image ;   Bilal Bawamia 2 Author Orcid Image ;   Karim Bennaceur 3 Author Orcid Image ;   Sarah Dunn 1 Author Orcid Image ;   Leanne Marsay 1 Author Orcid Image ;   Roland Amoah 3 Author Orcid Image ;   Adetayo Kasim 4 Author Orcid Image ;   Andrew Filby 5 Author Orcid Image ;   David Austin 2 Author Orcid Image ;   Helen Hancock 1 Author Orcid Image ;   Ioakim Spyridopoulos 3 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics
Rebecca Maier 1, MSc;  Bilal Bawamia 2, MBBS, MRCP;  Karim Bennaceur 3, PhD;  Sarah Dunn 1, MSc;  Leanne Marsay 1, PhD;  Roland Amoah 3, MBBS;  Adetayo Kasim 4, PhD;  Andrew Filby 5, PhD;  David Austin 2, MD, FRCP;  Helen Hancock 1, PhD;  Ioakim Spyridopoulos 3, MD, FRCP

1 Newcastle Clinical Trials Unit, Newcastle University , Newcastle Upon Tyne , GB

2 James Cook University Hospital , Middlesbrough , GB

3 Institute of Genetic Medicine, Newcastle University , Newcastle Upon Tyne , GB

4 Wolfson Research Institute for Health and Wellbeing, Durham University , Durham , GB

5 Flow Cytometry Core Facility, Newcastle University , Newcastle Upon Tyne , GB

Corresponding Author: